Literature DB >> 19889471

Developing Health Technology Assessment to address health care system needs.

Marcial Velasco Garrido1, Ansgar Gerhardus, John-Arne Røttingen, Reinhard Busse.   

Abstract

This article discusses the development of Heath Technology Assessment methods and HTA institutions, in regards to meeting the information needs of all levels and fields of health policy-making. On the one hand, HTA needs to expand and develop its methods. Although health products and health care services have been its preponderant focus to date, HTA should develop to increase its focus on the "technologies applied to health care" (i.e. the regulatory and policy measures for managing and organizing health care systems) and on policies in non-health care sectors. Such a knowledge synthesis for health policy should not necessarily be called HTA or conducted by narrowly defined HTA agencies. However, the trends observed in several European HTA agencies indicate the recognition of these development needs. Countries embarking on HTA should not consider establishing separate agencies for HTA, quality development, performance measurement, and health services development, but should rather combine these functions and goals into a common knowledge strategy for evidence-informed decision-making on health care and the health system.

Entities:  

Mesh:

Year:  2009        PMID: 19889471     DOI: 10.1016/j.healthpol.2009.10.002

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  12 in total

1.  Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada.

Authors:  Michèle Tony; Monika Wagner; Hanane Khoury; Donna Rindress; Tina Papastavros; Paul Oh; Mireille M Goetghebeur
Journal:  BMC Health Serv Res       Date:  2011-11-30       Impact factor: 2.655

Review 2.  Nanotherapeutics in the EU: an overview on current state and future directions.

Authors:  Anita Hafner; Jasmina Lovrić; Gorana Perina Lakoš; Ivan Pepić
Journal:  Int J Nanomedicine       Date:  2014-02-19

Review 3.  FROM TALK TO ACTION: POLICY STAKEHOLDERS, APPROPRIATENESS, AND SELECTIVE DISINVESTMENT.

Authors:  P Alison Paprica; Anthony J Culyer; Adam G Elshaug; Justin Peffer; Guillermo A Sandoval
Journal:  Int J Technol Assess Health Care       Date:  2015-08-20       Impact factor: 2.188

4.  Management of Medical Technology under the New Medical Policy Background in China.

Authors:  Suo-Wei Wu; Tong Chen; Ming Wu; Qi Pan; Yong Xuan; Liang-Yu Wei; Qin Wang; Chao Li; Jing-Chen Song
Journal:  Chin Med J (Engl)       Date:  2016-11-20       Impact factor: 2.628

5.  Randomized comparison of power Doppler ultrasonography-guided core-needle biopsy with open surgical biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma.

Authors:  Novella Pugliese; M Di Perna; I Cozzolino; G Ciancia; G Pettinato; P Zeppa; V Varone; S Masone; C Cerchione; R Della Pepa; L Simeone; C Giordano; V Martinelli; C Salvatore; F Pane; M Picardi
Journal:  Ann Hematol       Date:  2017-01-27       Impact factor: 3.673

6.  Ethics in HTA: Examining the "Need for Expansion".

Authors:  Payam Abrishami; Wija Oortwijn; Bjørn Hofmann
Journal:  Int J Health Policy Manag       Date:  2017-10-01

7.  Evaluation of China's public health system response to COVID-19.

Authors:  Pengfei Zhang; Jinghua Gao
Journal:  J Glob Health       Date:  2021-01-16       Impact factor: 4.413

8.  Health technology assessments as a mechanism for increased value for money: recommendations to the Global Fund.

Authors:  Yot Teerawattananon; Kate McQueston; Amanda Glassman; Jomkwan Yothasamut; Chaw Yin Myint
Journal:  Global Health       Date:  2013-08-21       Impact factor: 4.185

Review 9.  Health technology assessment of biosimilars worldwide: a scoping review.

Authors:  Bruna de Oliveira Ascef; Ana Carolina de Freitas Lopes; Patrícia Coelho de Soárez
Journal:  Health Res Policy Syst       Date:  2020-08-26

10.  Nurturing Societal Values in and Through Health Innovations Comment on "What Health System Challenges Should Responsible Innovation in Health Address?"

Authors:  Payam Abrishami; Sjoerd Repping
Journal:  Int J Health Policy Manag       Date:  2019-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.